All were clinically significant with PMD exceptionally so. Perhaps compare P2 study results of Daybue with the others for more clarity around this.
Share Price, page-11158
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.90 |
Change
-0.330(2.03%) |
Mkt cap ! $2.034B | |||
| Open | High | Low | Value | Volume |
| $16.33 | $16.37 | $15.78 | $9.238M | 578.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 224 | $16.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.02 | 710 | 1 |
View Market Depth
| Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |